Insider Trading & Ownership - Qualigen Therapeutics Inc. (QLGN)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Qualigen Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2022-06-22
Purchase		2022-06-22
4:55 pm		Qualigen Therapeutics Inc.QLGNPoirier Michael S.
Chairman and CEO		30,000$0.57$17,100210,207
(Indirect
Direct)		View
2022-06-14
Purchase		2022-06-15
4:05 pm		Qualigen Therapeutics Inc.QLGNBROIDRICK AMY S.
President/CSO		30,000$0.62$18,60034,500
(Direct)		View
2021-08-19
Purchase		2021-08-20
3:05 pm		Qualigen Therapeutics Inc.QLGNKruger Kurt H
Director		8,000$1.225$9,80018,000
(Direct)		View
2021-04-26
Purchase		2021-04-26
6:16 pm		Qualigen Therapeutics Inc.QLGNBROIDRICK AMY S.
EVP, Chief Strategy Officer		4,500$2.03$9,1354,500
(Direct)		View
2021-04-20
Purchase		2021-04-21
3:18 pm		Qualigen Therapeutics Inc.QLGNPoirier Michael S.
Chairman, CEO & President		11,005$1.8$19,809180,207
(Indirect
Direct)		View
2021-04-16
Purchase		2021-04-19
06:15 am		Qualigen Therapeutics Inc.QLGNLotz Christopher L.
Vice President of Finance, CFO		2,700$1.86$5,02212,541
(Direct)		View
2020-12-29
Purchase		2020-12-30
06:05 am		Qualigen Therapeutics Inc.QLGNKruger Kurt H
Director		4,000$2.935$11,74010,000
(Direct)		View
2020-11-20
Purchase		2020-11-23
9:11 pm		Qualigen Therapeutics Inc.QLGNKruger Kurt H
Director		6,000$3.4823$20,8946,000
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2022-07-11
Option Award		2022-08-04
4:17 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNAbdul-Ahad Wajdi
Vice President, R & D, CSO		80,000$080,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNLotz Christopher L.
Vice President of Finance, CFO		100,000$0100,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNARSHAD TARIQ
SVP/Chief Medical Officer		102,000$0102,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNRitter Ira E.
Director		40,000$040,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNEMERY SIDNEY W JR
Director		40,000$040,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNKruger Kurt H
Director		40,000$040,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNDavid Richard A.
Director		40,000$040,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNSinha Shishir K.
VP, COO & Secretary		100,000$0100,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNPoirier Michael S.
Chairman and CEO		375,000$0375,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNKorenberg Matthew E
Director		40,000$040,000
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNBROIDRICK AMY S.
President/CSO		130,000$0130,000
(Direct)		View
2021-12-08
Option Award		2021-12-10
06:15 am		N/A
2031-12-08		Qualigen Therapeutics Inc.QLGNBROIDRICK AMY S.
President/ChiefStrategyOfficer		300,000$0304,500
(Direct)		View
2021-12-08
Option Award		2021-12-10
06:15 am		N/A
2031-05-17		Qualigen Therapeutics Inc.QLGNARSHAD TARIQ
SVP/Chief Medical Officer		300,000$0300,000
(Direct)		View
2021-05-17
Option Award		2021-05-18
06:14 am		N/A
2031-05-17		Qualigen Therapeutics Inc.QLGNARSHAD TARIQ
SVP/Chief Medical Officer		100,000$0100,000
(Direct)		View
2020-12-07
Option Award		2020-12-29
4:44 pm		N/A
2030-12-07		Qualigen Therapeutics Inc.QLGNBROIDRICK AMY S.
Executive VP, CSO		150,000$0150,000
(Direct)		View
2020-12-07
Option Award		2020-12-08
12:31 pm		N/A
2030-12-07		Qualigen Therapeutics Inc.QLGNEMERY SIDNEY W JR
Director		50,000$050,000
(Direct)		View

Ownership		2020-12-07
4:32 pm		N/A
N/A		Qualigen Therapeutics Inc.QLGNEMERY SIDNEY W JR
Director		0$019,682
(Direct)		View
2020-08-27
Option Award		2020-08-28
2:01 pm		N/A
2030-08-27		Qualigen Therapeutics Inc.QLGNBROIDRICK AMY S.
Director		50,000$050,000
(Direct)		View
2020-06-06
Option Award		2020-06-08
9:27 pm		N/A
2030-06-06		Qualigen Therapeutics Inc.QLGNRitter Ira E.
Director		50,000$050,000
(Direct)		View
2020-06-06
Option Award		2020-06-08
9:26 pm		N/A
2030-06-06		Qualigen Therapeutics Inc.QLGNDavid Richard A.
Director		50,000$050,000
(Direct)		View
2020-06-06
Option Award		2020-06-08
9:26 pm		N/A
2030-06-06		Qualigen Therapeutics Inc.QLGNPoirier Michael S.
Chairman, President & CEO		1,000,000$01,000,000
(Direct)		View
2020-06-06
Option Award		2020-06-08
9:24 pm		N/A
2030-06-06		Qualigen Therapeutics Inc.QLGNAbdul-Ahad Wajdi
Vice President, R & D, CSO		500,000$0500,000
(Direct)		View
2020-06-06
Option Award		2020-06-08
9:23 pm		N/A
2030-06-06		Qualigen Therapeutics Inc.QLGNKruger Kurt H
Director		50,000$050,000
(Direct)		View
2020-06-06
Option Award		2020-06-08
9:23 pm		N/A
2030-06-06		Qualigen Therapeutics Inc.QLGNSinha Shishir K.
Vice President of Operations		500,000$0500,000
(Direct)		View
Goto 0, 1, Next